Akromegalili olguda gelişen postoperatif ciddi hipertansiyon
Akromegali, hipofiz adenomuna bağlı büyüme hormonu aşırı salınımı ve yükselmiş insülin benzeri büyüme faktörü-1 (IGF-1) ile karakterize olan bir hastalıktır. Bu hastalarda hipertansiyon %18-60 olguda görülüp yaşla birlikte artmaktadır ve diyastolik kan basıncında artış ön plandadır. Artan plazma hacmi, ANP düzeylerinde azalma, insülin direnci ve hastalık süresi, hipertansiyon riskini artıran eşlik eden faktörler hipertansiyona neden olur. muhtemeldir. Bu makalede pitüiter mikroadenoma sekonder akromegali bulunan bir kadın olguda postoperatif ciddi hipertansiyon tablosu sunulmuştur..
Postoperative severe hypertension in a patient with acromegaly
Acromegaly is a chronic disorder characterized by excessive secretion of growth hormone and elevated insulin-like growth factor-1 levels, usually due to a pituitary adenoma. In this patients, hypertension occurs in 18-60%, with a predominance of diastolic blood pressure elevation that increases in prevalence with age. Hypertension is likely due to increased plasma volume, to decreased ANP levels and to insulin resistance and disease duration are coexisting factors likely to increase the risk of hypertension. In this article, we report a case of a female patient with postoperative severe hypertension who presented with acromegaly secondary to a pituitary microadenoma.
___
- 1. Kraatz C, Benker G, Weber F, Lüdecke D, Hirche
H, Reinwein D. Acromegaly and hypertension:
Prevalence and relationship to the renin-angiotensinaldosterone
system. Klin Wochenschr. 1990;68:583-
7.
- 2. Bondanelli M, Ambrosio MR, degli Uberti EC.
Pathogenesis and prevalence of hypertension in
acromegaly. Pituitary. 2001;4:239-49.
- 3. Minniti G, Moroni C, Jaffrain-Rea ML, et al.
Prevalance of hypertension in acromegalic patients:
clinical measurement versus 24-hour ambulatory
blood pressure monitoring. Clin Endocrinol.
1998;48:149-52
- 4. Fedrizzi D, Rodrigues TC, Costenaro F, Scalco R,
Czepielewski MA. Hypertension-related factors in
patients with active and inactive acromegaly. Arq
Bras Endocrinol Metabol. 2011;55:468-74
- 5. Kamenicky P, Viengchareun S, Blanchard A, Meduri
G, Zizzari P, Imbert-Teboul M et al. Epithelial
sodium channel is a key mediator of growth
hormone-induced sodium retention in acromegaly.
Endocrinology. 2008;149:3294–305.
- 6. Colao A, Spiezia S, Cerbone G, Pivonello R,
Marzullo P, Ferone D et al. Increased arterial intimamedia
thickness by B-M mode echodoppler
ultrasonography in acromegaly. Clin Endocrinol
(Oxf). 2001;54:515-24.
- 7. Akgul E, Tokgozoglu SL, Erbas T, Kabakci G,
Aytemir K, Haznedaroglu I et al. Evaluation of the
impact of treatment on endothelial function and
cardiac performance in acromegaly.
Echocardiography. 2010;27:990-6
- 8. Cafiero T, Cavallo LM, Frangiosa A, Burrelli R,
Gargiulo G, Cappabianca P et al. Clinical comparison
of remifentanil–sevoflurane vs. remifentanil–
propofol for endoscopic endonasal transphenoidal
surgery. Eur J Anaesthesiol. 2007; 24:441-6.
- 9. Asouhidou I, Trikoupi A. Esmolol reduces
anesthetic requirements thereby facilitating early
extubation; a prospective controlled study in patients
undergoing intracranial surgery. BMC Anesthesiol.
2015;15:172.
- 10. Kim SH, Stoicea N, Soghomonyan S, Bergese SD.
Remifentanil-acute opioid tolerance and opioidinduced
hyperalgesia: a systematic review. Am J
Ther. 2015;22:e62-74.
- 11. Nemergut EC, Zuo Z, Jane JA, Laws ER. Diabetes
insipidus after transsphenoidal surgery: a review of
881 patients. J Neurosurg. 2005;103:448–54.